Back to search

Article

Epigenetic regulation of miR-218 and its host gene, SLIT2 in breast cancer

2016-03-31

Abstract excerpt

Numerous studies have shown that microRNAs are deregulated in various types of cancer. Although miR-218 aberrant expression has been documented in various cancers, the epigenetic regulation of miR-218 is unclear in breast cancer. Our results demonstrate that treatment of breast cancer cells with demethylating agent, 5-azacytidine, resulted in increased expression of miR-218 and its host gene slit-2, suggesting tha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
27205db5-4033-5f99-86ea-1777bfaa2107
DOI
10.1101/046482
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigenetic regulation of miR-218 and its host gene, SLIT2 in breast cancerDOI 10.1101/046482
Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathwaySemantic proximity
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosisSemantic proximity
Down-Regulation of miR-218-2 and Its Host Gene SLIT3 Cooperate to Promote Invasion and Progression of Thyroid CancerSemantic proximity
Up-Regulation of miR-182 Expression after Epigenetic Modulation of Human Melanoma CellsSemantic proximity
mir-218 modulates ARF6 expression and inhibits pancreatic ductal adenocarcinoma invasionSemantic proximity
Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4Semantic proximity
SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.Semantic proximity
SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasmSemantic proximity
Select a neighboring publication to make it the new centre.